Highlighting new phylogenetic specificities of Crohn's disease microbiota

Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different meth...

Full description

Saved in:
Bibliographic Details
Published inInflammatory bowel diseases Vol. 17; no. 1; pp. 185 - 192
Main Authors Mondot, S., Kang, S., Furet, J. P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Doré, J., Leclerc, M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford University Press 01.01.2011
Wiley Subscription Services, Inc., A Wiley Company
Lippincott, Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria.ResultsEven though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected “healthy specific” molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level.ConclusionsThese two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011;)
AbstractList BackgroundRecent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria.ResultsEven though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected “healthy specific” molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level.ConclusionsThese two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011;)
Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).BACKGROUNDRecent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).Fecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria.METHODSFecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria.Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected "healthy specific" molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level.RESULTSEven though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected "healthy specific" molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level.These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool.CONCLUSIONSThese two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool.
Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Fecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria. Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected "healthy specific" molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level. These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool.
Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were collected from 16 healthy individuals and 16 CD patients (age-and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria. Results: Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected "healthy specific'' molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level. Conclusions: These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool.
Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria.ResultsEven though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected “healthy specific” molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level.ConclusionsThese two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011;)
Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were collected from 16 healthy individuals and 16 CD patients (age‐ and sex‐matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real‐time polymerase chain reaction (PCR) methods using primers designed using a high‐throughput in‐house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom‐designed phylogenetic microarray for intestinal bacteria. Results: Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected “healthy specific” molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level. Conclusions: These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011;)
Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were collected from 16 healthy individuals and 16 CD patients (age- and sex-matched). The DNA extracted from these samples were subjected to two different methods of microbiome analysis. Specific bacterial groups were quantified by real-time polymerase chain reaction (PCR) methods using primers designed using a high-throughput in-house bioinformatics pipeline. The same DNA extracts were also used to produce fluorescently labeled cRNA amplicons to interrogate a custom-designed phylogenetic microarray for intestinal bacteria. Results: Even though the intersubject variability was high, differences in the fecal microbiomes of healthy and CD patients were detected. Faecalibacterium prausnitzii and Escherichia coli were more represented in healthy and ileal CD patients, respectively. Additionally, probes specific for Ruminococcus bromii, Oscillibacter valericigenes, Bifidobacterium bifidum, and Eubacterium rectale produced stronger hybridization signals with the DNA samples from healthy subjects. Conversely, species overrepresented in CD patients were E. coli, Enterococcus faecium, and species from the Proteobacteria not normally found in the healthy human GI tract. Furthermore, we detected 'healthy specific' molecular species or operational taxonomic units (OTUs) that are not closely related to any known species (Faecalibacterium, Subdoligranulum, and Oscillospora species), indicating that the phylogenetic dysbiosis is broader than at strain or species level. Conclusions: These two techniques of microbiome analysis provided a statistically robust new picture of the dysbiosis in fecal microbiota from ileal CD patients. Specifically, we identified a set of six species discriminant for CD, which provides a preliminary diagnostic tool. (Inflamm Bowel Dis 2011; )
Author Leclerc, M.
Aguirre de Carcer, D.
Marteau, P.
Kang, S.
McSweeney, C.
Mondot, S.
Doré, J.
Morrison, M.
Furet, J. P.
Author_xml – sequence: 1
  givenname: S.
  surname: Mondot
  fullname: Mondot, S.
  organization: 1UMR1319 MICALIS, INRA, Domaine de Vilvert, 78350 Jouy en Josas, France
– sequence: 2
  givenname: S.
  surname: Kang
  fullname: Kang, S.
  organization: 2CSIRO, St Lucia, Queensland, Australia
– sequence: 3
  givenname: J. P.
  surname: Furet
  fullname: Furet, J. P.
  organization: 1UMR1319 MICALIS, INRA, Domaine de Vilvert, 78350 Jouy en Josas, France
– sequence: 4
  givenname: D.
  surname: Aguirre de Carcer
  fullname: Aguirre de Carcer, D.
  organization: 2CSIRO, St Lucia, Queensland, Australia
– sequence: 5
  givenname: C.
  surname: McSweeney
  fullname: McSweeney, C.
  organization: 2CSIRO, St Lucia, Queensland, Australia
– sequence: 6
  givenname: M.
  surname: Morrison
  fullname: Morrison, M.
  organization: 2CSIRO, St Lucia, Queensland, Australia
– sequence: 7
  givenname: P.
  surname: Marteau
  fullname: Marteau, P.
  organization: 3AP-HP, Hôpital Lariboisière et Université Denis Diderot Paris 7, Paris, France
– sequence: 8
  givenname: J.
  surname: Doré
  fullname: Doré, J.
  organization: 1UMR1319 MICALIS, INRA, Domaine de Vilvert, 78350 Jouy en Josas, France
– sequence: 9
  givenname: M.
  surname: Leclerc
  fullname: Leclerc, M.
  organization: 1UMR1319 MICALIS, INRA, Domaine de Vilvert, 78350 Jouy en Josas, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20722058$$D View this record in MEDLINE/PubMed
https://hal.science/hal-01000994$$DView record in HAL
BookMark eNp9kV1r2zAUhsXoWD-2i_2BYdig20VaybIs6bLLPhII7Ga7FrJ9nJziSJ5lt-Tf72RpOygsCCEhnnP0nvc9ZychBmDsreBXgvP8GqvmKheFLF-wM6FkOStMUZzQnWsz49aaU3ae0i2htOwrdppznedcmTO2XOB609EeMayzAPdZv9l1cQ0BRqyz1EONLdY4IqQsttl8iJtwmbIGE_gE2RbrIVYYR_-avWx9l-DNw3nBfn37-nO-mK1-fF_Ob1azWhWWpFVCSy8t_V_XOlcqr4wvhQUo28ZaZbjm3ChvTKullCAEiVW80QUo2bSlvGCfDn03vnP9gFs_7Fz06BY3K7d_4-QJDV3cCWIvD2w_xN8TpNFtMdXQdT5AnJIz5JoRlnMiPx4lBRfa6lIIS-j7Z-htnIZAMzspSquNytW-4bsHaqq20DwpfbT-3xxkYEoDtE-I4G4fq6NY3d9Yib1-xlIifsQYxsFjd6ziHjvY_b-1W37-8ljx4VARp_6IlD99Zro8
CitedBy_id crossref_primary_10_1016_j_ijmm_2014_02_009
crossref_primary_10_1038_nrg3182
crossref_primary_10_3389_fcimb_2023_1279172
crossref_primary_10_1038_nrgastro_2011_3
crossref_primary_10_1038_ismej_2010_177
crossref_primary_10_2174_1389450122666210623125603
crossref_primary_10_1097_01_MIB_0000435759_05577_12
crossref_primary_10_3389_fvets_2016_00011
crossref_primary_10_1186_1471_230X_13_131
crossref_primary_10_3389_fcimb_2018_00281
crossref_primary_10_1371_journal_pone_0034233
crossref_primary_10_3390_genes15060729
crossref_primary_10_3390_microorganisms4020020
crossref_primary_10_1097_MIB_0000000000000468
crossref_primary_10_7180_kmj_23_115
crossref_primary_10_1371_journal_pone_0187852
crossref_primary_10_1371_journal_pone_0114352
crossref_primary_10_1128_genomeA_00022_14
crossref_primary_10_1016_j_micpath_2021_104966
crossref_primary_10_3390_nu7010045
crossref_primary_10_3748_wjg_v31_i2_100024
crossref_primary_10_1155_2022_7813278
crossref_primary_10_3233_NUA_150058
crossref_primary_10_1097_MIB_0000000000000215
crossref_primary_10_3390_cells10113202
crossref_primary_10_1111_cen3_12401
crossref_primary_10_1038_s41396_020_0678_3
crossref_primary_10_1016_j_bcp_2023_115949
crossref_primary_10_1016_j_bpg_2017_09_009
crossref_primary_10_1039_D0FO01439G
crossref_primary_10_1016_j_psj_2020_03_019
crossref_primary_10_1038_srep13282
crossref_primary_10_3389_fcimb_2021_647048
crossref_primary_10_1016_j_actatropica_2021_105835
crossref_primary_10_1186_1471_230X_13_113
crossref_primary_10_1080_20002297_2025_2473246
crossref_primary_10_1016_j_autrev_2019_03_006
crossref_primary_10_1002_jssc_201700368
crossref_primary_10_1136_gutjnl_2023_330002
crossref_primary_10_3390_ijms18122645
crossref_primary_10_3389_fmicb_2022_856165
crossref_primary_10_1155_2014_872725
crossref_primary_10_3390_ijms22041623
crossref_primary_10_1016_j_chroma_2015_12_031
crossref_primary_10_1016_j_jes_2022_02_048
crossref_primary_10_1038_s41467_023_42005_y
crossref_primary_10_1093_aje_kwr400
crossref_primary_10_1097_MIB_0000000000000590
crossref_primary_10_3389_fcimb_2024_1393809
crossref_primary_10_1186_s12864_016_2678_2
crossref_primary_10_1128_mbio_03801_21
crossref_primary_10_3920_BM2016_0231
crossref_primary_10_1038_nrmicro3315
crossref_primary_10_1089_ees_2014_0518
crossref_primary_10_3389_fimmu_2020_585431
crossref_primary_10_1126_science_aan4526
crossref_primary_10_1016_j_clim_2020_108380
crossref_primary_10_1038_s41598_023_33163_6
crossref_primary_10_1002_ibd_21751
crossref_primary_10_1002_ibd_21874
crossref_primary_10_1016_j_pharmthera_2019_03_006
crossref_primary_10_1016_j_gtc_2012_08_003
crossref_primary_10_36233_0372_9311_2018_1_112_119
crossref_primary_10_1016_j_gtc_2012_08_001
crossref_primary_10_1016_j_gastrohep_2015_01_004
crossref_primary_10_1093_jas_skad240
crossref_primary_10_1016_j_jff_2017_10_030
crossref_primary_10_1016_j_scib_2017_07_011
crossref_primary_10_1089_jmf_2017_0138
crossref_primary_10_1097_MIB_0b013e3182a38a92
crossref_primary_10_1016_j_jneuroim_2018_07_015
crossref_primary_10_7453_gahmj_2013_100
crossref_primary_10_15690_pf_v18i5_2294
crossref_primary_10_3389_fimmu_2021_761981
crossref_primary_10_1002_ibd_21864
crossref_primary_10_1111_hel_12748
crossref_primary_10_1016_j_advms_2016_09_001
crossref_primary_10_1007_s12223_022_00951_y
crossref_primary_10_14232_abs_2023_2_203_220
crossref_primary_10_1155_2013_636785
crossref_primary_10_3389_fmicb_2019_00268
crossref_primary_10_1159_000354678
crossref_primary_10_3390_microorganisms8060907
crossref_primary_10_1016_j_obmed_2020_100226
crossref_primary_10_1007_s12026_013_8413_z
crossref_primary_10_1111_cmi_12360
crossref_primary_10_1155_2013_302398
crossref_primary_10_3390_nu4081095
crossref_primary_10_1099_mic_0_000587
crossref_primary_10_1111_cei_12474
crossref_primary_10_4240_wjgs_v13_i7_678
crossref_primary_10_4291_wjgp_v11_i3_64
crossref_primary_10_1111_ajt_12760
crossref_primary_10_1371_journal_pone_0048224
crossref_primary_10_1080_10408398_2014_941457
crossref_primary_10_3389_fimmu_2020_01192
crossref_primary_10_3390_ijms22095005
crossref_primary_10_1128_microbiolspec_GPP3_0053_2018
crossref_primary_10_1007_s00248_013_0245_9
crossref_primary_10_1016_j_imlet_2020_03_001
crossref_primary_10_1186_1471_230X_13_20
crossref_primary_10_3748_wjg_v20_i34_12102
crossref_primary_10_1038_nrgastro_2011_133
crossref_primary_10_1371_journal_pone_0137429
crossref_primary_10_1186_s12989_018_0265_1
crossref_primary_10_1042_BST0391067
crossref_primary_10_1136_gutjnl_2019_319523
crossref_primary_10_1039_D4FO05633G
crossref_primary_10_1371_journal_pone_0198342
crossref_primary_10_3389_fnut_2022_822020
crossref_primary_10_1038_s41598_022_23757_x
crossref_primary_10_1016_j_alit_2024_12_006
crossref_primary_10_1016_j_jaut_2023_103062
crossref_primary_10_1186_1475_2891_13_61
crossref_primary_10_3390_pathogens8030126
crossref_primary_10_1016_j_bpg_2013_03_005
crossref_primary_10_1016_j_ijmm_2015_10_002
crossref_primary_10_1177_0300060518821790
crossref_primary_10_3390_ani12223221
crossref_primary_10_1016_j_biopha_2020_109910
crossref_primary_10_1109_TCBB_2020_3018138
crossref_primary_10_3389_fmicb_2016_01479
crossref_primary_10_3382_ps_pey085
crossref_primary_10_1016_j_pt_2012_05_001
crossref_primary_10_1017_S0007114512001857
crossref_primary_10_3390_cimb44070215
crossref_primary_10_1016_j_anaerobe_2017_06_002
crossref_primary_10_1038_s41598_023_42220_z
crossref_primary_10_1371_journal_pone_0161174
crossref_primary_10_1371_journal_pone_0055468
crossref_primary_10_3945_jn_117_255851
crossref_primary_10_3389_fimmu_2022_923754
crossref_primary_10_3389_fimmu_2017_00942
crossref_primary_10_1016_j_jff_2016_04_016
crossref_primary_10_3233_NHA_200098
crossref_primary_10_1007_s11605_023_05677_x
crossref_primary_10_1371_journal_pone_0023035
crossref_primary_10_1099_ijsem_0_005066
crossref_primary_10_1016_j_jff_2019_02_012
crossref_primary_10_3389_fphar_2021_797605
crossref_primary_10_1111_j_1600_065X_2011_01079_x
crossref_primary_10_1186_s40168_018_0398_3
crossref_primary_10_1038_nmeth_2693
crossref_primary_10_1136_gutjnl_2014_307289
crossref_primary_10_1128_CMR_00085_17
crossref_primary_10_1152_ajpgi_00190_2011
crossref_primary_10_1002_hep_28572
crossref_primary_10_1093_ibd_izy085
crossref_primary_10_3389_fcimb_2021_703126
crossref_primary_10_1186_s12859_017_1968_2
crossref_primary_10_1080_19490976_2024_2337269
crossref_primary_10_1155_2014_567929
crossref_primary_10_1080_19490976_2022_2028366
crossref_primary_10_1038_nrgastro_2012_14
crossref_primary_10_1097_MIB_0000000000000750
crossref_primary_10_1016_j_dld_2012_04_014
crossref_primary_10_3389_fmicb_2017_00429
crossref_primary_10_1016_j_anaerobe_2020_102244
crossref_primary_10_1111_ijfs_15207
crossref_primary_10_1155_2014_716579
crossref_primary_10_1007_s00253_014_6046_3
crossref_primary_10_3945_jn_116_238816
crossref_primary_10_1093_ecco_jcc_jjv203
crossref_primary_10_3390_nu9121349
crossref_primary_10_1371_journal_pone_0309921
crossref_primary_10_1080_19490976_2022_2046244
crossref_primary_10_1093_femsre_fux027
crossref_primary_10_3389_fimmu_2020_01138
crossref_primary_10_1016_j_bbi_2024_05_037
crossref_primary_10_1016_j_foodres_2021_110716
crossref_primary_10_1007_s12263_011_0229_7
crossref_primary_10_1016_j_jconrel_2023_09_049
crossref_primary_10_1016_j_cegh_2023_101497
crossref_primary_10_1111_jam_13595
crossref_primary_10_1002_ajp_23061
crossref_primary_10_3389_fcvm_2021_767692
crossref_primary_10_3390_ijms22063076
crossref_primary_10_1007_s00394_021_02764_0
crossref_primary_10_1038_ismej_2013_80
crossref_primary_10_3390_biom14081018
crossref_primary_10_1128_JCM_03128_13
crossref_primary_10_1128_JB_00040_11
crossref_primary_10_1093_jas_skad401
crossref_primary_10_31083_j_fbe1602013
crossref_primary_10_1038_nrgastro_2014_188
crossref_primary_10_1096_fj_202400168RR
crossref_primary_10_1371_journal_pone_0146557
crossref_primary_10_1016_j_micpath_2018_03_017
crossref_primary_10_3390_ijms25042109
crossref_primary_10_1146_annurev_publhealth_032013_182426
crossref_primary_10_1016_j_mib_2013_06_003
crossref_primary_10_3390_microorganisms9050977
crossref_primary_10_1007_s10620_013_2844_1
crossref_primary_10_3389_fmed_2022_788992
crossref_primary_10_1111_apt_12699
crossref_primary_10_3389_fimmu_2015_00489
crossref_primary_10_3389_fimmu_2019_02754
crossref_primary_10_1038_ncomms5714
crossref_primary_10_1128_iai_00583_21
crossref_primary_10_1136_gutjnl_2015_309184
crossref_primary_10_1038_emm_2017_24
crossref_primary_10_1371_journal_pone_0027949
crossref_primary_10_1152_ajpgi_00509_2010
crossref_primary_10_1371_journal_pone_0140301
crossref_primary_10_1080_19490976_2023_2172670
crossref_primary_10_1186_s12866_018_1367_5
crossref_primary_10_1111_biom_12956
crossref_primary_10_1016_j_neuint_2019_104475
crossref_primary_10_1371_journal_ppat_1004911
crossref_primary_10_3390_pharmaceutics15061569
crossref_primary_10_3390_molecules24203770
crossref_primary_10_1038_srep15920
crossref_primary_10_1053_j_gastro_2011_01_054
crossref_primary_10_1016_j_ijbiomac_2023_128265
Cites_doi 10.1038/ng.175
10.1002/ibd.20828
10.1128/AEM.00474-06
10.1111/j.1462-2920.2008.01706.x
10.1111/j.1574-6941.2009.00671.x
10.1128/AEM.00556-06
10.1093/nar/gki198
10.1128/AEM.00325-08
10.1073/pnas.0804812105
10.1093/bioinformatics/bti394
10.1128/AEM.65.11.4799-4807.1999
10.1073/pnas.0706625104
10.1128/AEM.71.3.1501-1506.2005
10.1136/gut.2005.073817
10.1136/gut.2005.076604
10.1136/gut.53.1.1
10.1073/pnas.0808723105
10.1016/j.cell.2007.08.017
10.1053/j.gastro.2007.11.059
10.1111/j.1462-2920.2009.01982.x
10.1146/annurev.mi.31.100177.000543
10.1053/j.gastro.2004.04.061
10.1097/01.mib.0000235828.09305.0c
10.1128/JCM.41.7.2915-2923.2003
10.1053/j.gastro.2004.01.063
10.1016/j.mimet.2007.12.004
10.1136/gut.52.2.237
10.1126/science.1110591
10.1046/j.1365-2036.1999.00630.x
10.1136/gut.2006.118646
10.1038/nature07450
ContentType Journal Article
Copyright Copyright © 2010 Crohn's & Colitis Foundation of America, Inc. 2010
Copyright © 2010 Crohn's & Crohn's & Colitis Foundation of America, Inc.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Copyright © 2010 Crohn's & Colitis Foundation of America, Inc. 2010
– notice: Copyright © 2010 Crohn's & Crohn's & Colitis Foundation of America, Inc.
– notice: Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7T5
8FD
FR3
H94
P64
RC3
7X8
1XC
DOI 10.1002/ibd.21436
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
AIDS and Cancer Research Abstracts
Genetics Abstracts
Immunology Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)
MEDLINE - Academic
MEDLINE



AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-4844
EndPage 192
ExternalDocumentID oai_HAL_hal_01000994v1
20722058
10_1002_ibd_21436
IBD21436
10.1002/ibd.21436
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: S. Mondot was supported by a fellowship from the Région Ile de France
GroupedDBID ---
.Z2
0R~
1OC
3WU
4.4
48X
53G
5GY
5VS
5WD
66C
7O~
8-0
8-1
8UM
AAAXR
AABZA
AACZT
AAKAS
AAPQZ
AAPXW
AARHZ
AARTV
AAUAY
AAVAP
AAYEP
ABBUW
ABDFA
ABEJV
ABGNP
ABJNI
ABNHQ
ABOCM
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVJ
ABXVV
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACUTJ
ACWDW
ACWRI
ACXNZ
ACXQS
ACYHN
ADBBV
ADBIZ
ADGZP
ADIPN
ADQBN
ADRTK
ADVEK
ADZCM
AENEX
AETBJ
AFBPY
AFFZL
AFOFC
AFTRI
AFXAL
AFZJQ
AGINJ
AGQXC
AGUTN
AHMBA
AHMMS
AIJEX
AIZYK
AJAOE
AJEEA
AJNYG
ALMA_UNASSIGNED_HOLDINGS
ATGXG
AWKKM
BAYMD
BCRHZ
BEYMZ
BOYCO
BTRTY
C45
CDBKE
CS3
DAKXR
DR2
DU5
E.X
E3Z
EBS
EJD
ENERS
EX3
F5P
FECEO
FL-
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H0~
HZ~
IN~
IX1
KBUDW
KOP
KSI
KSN
LAW
LH4
LW6
MHKGH
NNB
NOMLY
NOYVH
NU-
NVLIB
N~7
N~B
O9-
OAUYM
OCZFY
ODMLO
OIG
OJZSN
OPAEJ
OVD
OWPYF
P2P
PAFKI
PQQKQ
QRW
ROL
ROX
RUSNO
RX1
S4S
TEORI
V2E
W99
WOW
XV2
YAYTL
YKOAZ
YXANX
ZFV
31~
8F7
AAJQQ
AAPGJ
AAUQX
AAWDT
ACFRR
ACZBC
AFUWQ
AFYAG
AGKRT
AGMDO
AHRYX
APJGH
AQDSO
AQKUS
AVNTJ
EIHJH
H13
IAO
IHR
ITC
MBLQV
OCUKA
ORVUJ
TMA
WOQ
Y6R
7X7
88E
8FI
8FJ
AAYXX
ABUWG
ACVCV
ADMTO
ADNBA
AEMQT
AFFQV
AFKRA
AGORE
AHGBF
AJBYB
AJDVS
AJNCP
ALXQX
BENPR
CCPQU
CITATION
FYUFA
HMCUK
JXSIZ
M1P
OBFPC
PHGZM
PHGZT
PSQYO
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7T5
8FD
FR3
H94
P64
RC3
7X8
1XC
ID FETCH-LOGICAL-c5496-4b173a39220cc72552b8a619ee6fd9958070085a88f7333e1120750d74e53df63
IEDL.DBID DR2
ISSN 1078-0998
1536-4844
IngestDate Fri May 09 12:17:55 EDT 2025
Fri Jul 11 11:47:59 EDT 2025
Fri Jul 11 10:12:57 EDT 2025
Fri Jul 25 21:52:07 EDT 2025
Wed Feb 19 02:41:15 EST 2025
Thu Apr 24 22:53:15 EDT 2025
Tue Jul 01 04:19:17 EDT 2025
Wed Jan 22 16:35:15 EST 2025
Sat Feb 08 08:13:07 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords microbiota
16S rRNA
microarray
Crohn's disease
dysbiosis
HOMEOSTASIS
FECAL MICROBIOTA
SMOKING
PREVALENCE
COMMENSALS
CLINICAL-COURSE
SOFTWARE
DIVERSITY
INFLAMMATORY BOWEL DISEASES
16S RIBOSOMAL-RNA
Language English
License Copyright © 2010 Crohn's & Crohn's & Colitis Foundation of America, Inc.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5496-4b173a39220cc72552b8a619ee6fd9958070085a88f7333e1120750d74e53df63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ORCID 0000-0001-8684-2847
0000-0003-3668-3168
OpenAccessLink https://academic.oup.com/ibdjournal/article-pdf/17/1/185/23846614/00054725-201101000-00026.pdf
PMID 20722058
PQID 3169785250
PQPubID 996336
PageCount 8
ParticipantIDs hal_primary_oai_HAL_hal_01000994v1
proquest_miscellaneous_821481900
proquest_miscellaneous_1017976119
proquest_journals_3169785250
pubmed_primary_20722058
crossref_primary_10_1002_ibd_21436
crossref_citationtrail_10_1002_ibd_21436
wiley_primary_10_1002_ibd_21436_IBD21436
oup_primary_10_1002_ibd_21436
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20110101
January 2011
2011-01-00
2011-Jan
2011
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – month: 01
  year: 2011
  text: 20110101
  day: 01
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Hoboken
– name: England
– name: Baltimore
PublicationTitle Inflammatory bowel diseases
PublicationTitleAlternate Inflamm Bowel Dis
PublicationYear 2011
Publisher Oxford University Press
Wiley Subscription Services, Inc., A Wiley Company
Lippincott, Williams & Wilkins
Publisher_xml – name: Oxford University Press
– name: Wiley Subscription Services, Inc., A Wiley Company
– name: Lippincott, Williams & Wilkins
References 2007; 104
2009; 68
2004; 127
2004; 126
2006; 72
2006; 12
2010
2006; 55
2004; 4
1999; 65
2005; 21
2008; 105
2008; 10
2008; 74
2008; 72
2003; 52
2007; 56
2009; 11
2004; 53
2007; 131
1999; 13
1977; 31
2005; 308
2008; 456
2005; 71
2008; 134
2008; 40
2003; 41
2005; 33
2009; 15
Frank (R10-26-20140212) 2007; 104
Manichanh (R15-26-20140212) 2006; 55
Chessel (R28-26-20140212) 2004; 4
Culhane (R29-26-20140212) 2005; 21
Seksik (R3-26-20140212) 2009; 15
Bull (R11-26-20140212) 2003; 41
Furet (R26-26-20140212) 2009; 68
Salazar (R31-26-20140212) 2008; 74
DarfeuilleMichaud (R12-26-20140212) 2004; 127
Vaishnava (R7-26-20140212) 2008; 105
Savage (R9-26-20140212) 1977; 31
Sokol (R18-26-20140212) 2008; 105
Nuding (R33-26-20140212) 2007; 56
Garrett (R8-26-20140212) 2007; 131
Barrett (R1-26-20140212) 2008; 40
Fu (R24-26-20140212) 2008; 72
Eckburg (R14-26-20140212) 2005; 308
Schloss (R22-26-20140212) 2005; 71
Schloss (R23-26-20140212) 2006; 72
Seksik (R17-26-20140212) 2003; 52
Katoh (R20-26-20140212) 2005; 33
Sartor (R5-26-20140212) 2008; 134
MartinezMedina (R32-26-20140212) 2006; 12
Cosnes (R2-26-20140212) 1999; 13
Tamboli (R16-26-20140212) 2004; 53
Loy (R25-26-20140212) 2008; 10
Ashelford (R21-26-20140212) 2006; 72
Bouskra (R6-26-20140212) 2008; 456
Loftus (R4-26-20140212) 2004; 126
Tap (R30-26-20140212) 2009; 11
Suau (R13-26-20140212) 1999; 65
Marteau (R19-26-20140212) 2006; 55
References_xml – volume: 41
  start-page: 2915
  year: 2003
  end-page: 2923
  article-title: Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease
  publication-title: J Clin Microbiol
– volume: 134
  start-page: 577
  year: 2008
  end-page: 594
  article-title: Microbial influences in inflammatory bowel diseases
  publication-title: Gastroenterology
– volume: 104
  start-page: 13780
  year: 2007
  end-page: 13785
  article-title: Molecular‐phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
  publication-title: Proc Natl Acad Sci U S A
– volume: 65
  start-page: 4799
  year: 1999
  end-page: 4807
  article-title: Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut
  publication-title: Appl Environ Microbiol
– volume: 53
  start-page: 1
  year: 2004
  end-page: 4
  article-title: Dysbiosis in inflammatory bowel disease
  publication-title: Gut
– volume: 21
  start-page: 2789
  year: 2005
  end-page: 2790
  article-title: MADE4: an R package for multivariate analysis of gene expression data
  publication-title: Bioinformatics (Oxford)
– volume: 105
  start-page: 16731
  year: 2008
  end-page: 16736
  article-title: Faecalibacterium prausnitzii is an anti‐inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
  publication-title: Proc Natl Acad Sci U S A
– volume: 456
  start-page: 507
  year: 2008
  end-page: 510
  article-title: Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
  publication-title: Nature
– volume: 40
  start-page: 955
  year: 2008
  end-page: 962
  article-title: Genome‐wide association defines more than 30 distinct susceptibility loci for Crohn's disease
  publication-title: Nat Genet
– volume: 13
  start-page: 1403
  year: 1999
  end-page: 1411
  article-title: Effects of current and former cigarette smoking on the clinical course of Crohn's disease
  publication-title: Aliment Pharmacol Ther
– volume: 56
  start-page: 1240
  year: 2007
  end-page: 1247
  article-title: Reduced mucosal antimicrobial activity in Crohn's disease of the colon
  publication-title: Gut
– volume: 15
  start-page: 734
  year: 2009
  end-page: 741
  article-title: Effects of light smoking consumption on the clinical course of Crohn's disease
  publication-title: Inflamm Bowel Dis
– volume: 31
  start-page: 107
  year: 1977
  end-page: 133
  article-title: Microbial ecology of the gastrointestinal tract
  publication-title: Annu Rev Microbiol
– year: 2010
  article-title: Dysbiosis of faecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray
  publication-title: Inflamm Bowel Dis
– volume: 4
  start-page: 5
  year: 2004
  end-page: 10
  article-title: The ade4 package. I. One‐table methods
  publication-title: R News
– volume: 11
  start-page: 2574
  year: 2009
  end-page: 2584
  article-title: Towards the human intestinal microbiota phylogenetic core
  publication-title: Environ Microbiol
– volume: 52
  start-page: 237
  year: 2003
  end-page: 242
  article-title: Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
  publication-title: Gut
– volume: 71
  start-page: 1501
  year: 2005
  end-page: 1506
  article-title: Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness
  publication-title: Appl Environ Microbiol
– volume: 72
  start-page: 263
  year: 2008
  end-page: 267
  article-title: PRISE (PRImer SElector): software for designing sequence‐selective PCR primers
  publication-title: J Microbiol Methods
– volume: 74
  start-page: 4737
  year: 2008
  end-page: 4745
  article-title: Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria
  publication-title: Appl Environ Microbiol
– volume: 72
  start-page: 6773
  year: 2006
  end-page: 6779
  article-title: Introducing SONS, a tool for operational taxonomic unit‐based comparisons of microbial community memberships and structures
  publication-title: Appl Environ Microbiol
– volume: 105
  start-page: 20858
  year: 2008
  end-page: 20863
  article-title: Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host‐microbial interface
  publication-title: Proc Natl Acad Sci U S A
– volume: 131
  start-page: 33
  year: 2007
  end-page: 45
  article-title: Communicable ulcerative colitis induced by T‐bet deficiency in the innate immune system
  publication-title: Cell
– volume: 55
  start-page: 205
  year: 2006
  end-page: 211
  article-title: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
  publication-title: Gut
– volume: 308
  start-page: 1635
  year: 2005
  end-page: 1638
  article-title: Diversity of the human intestinal microbial flora
  publication-title: Science (New York)
– volume: 68
  start-page: 351
  year: 2009
  end-page: 362
  article-title: Comparative assessment of human and farm animal faecal microbiota using real‐time quantitative PCR
  publication-title: FEMS Microbiol Ecol
– volume: 10
  start-page: 2894
  year: 2008
  end-page: 2898
  article-title: probeCheck—a central resource for evaluating oligonucleotide probe coverage and specificity
  publication-title: Environ Microbiol
– volume: 126
  start-page: 1504
  year: 2004
  end-page: 1517
  article-title: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
  publication-title: Gastroenterology
– volume: 55
  start-page: 842
  year: 2006
  end-page: 847
  article-title: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
  publication-title: Gut
– volume: 72
  start-page: 5734
  year: 2006
  end-page: 5741
  article-title: New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras
  publication-title: Appl Environ Microbiol
– volume: 33
  start-page: 511
  year: 2005
  end-page: 518
  article-title: MAFFT version 5: improvement in accuracy of multiple sequence alignment
  publication-title: Nucleic Acids Res
– volume: 12
  start-page: 1136
  year: 2006
  end-page: 1145
  article-title: Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis
  publication-title: Inflamm Bowel Dis
– volume: 127
  start-page: 412
  year: 2004
  end-page: 421
  article-title: High prevalence of adherent‐invasive Escherichia coli associated with ileal mucosa in Crohn's disease
  publication-title: Gastroenterology
– volume: 40
  start-page: 955
  year: 2008
  ident: R1-26-20140212
  publication-title: Nat Genet
  doi: 10.1038/ng.175
– volume: 15
  start-page: 734
  year: 2009
  ident: R3-26-20140212
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.20828
– volume: 72
  start-page: 6773
  year: 2006
  ident: R23-26-20140212
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.00474-06
– volume: 10
  start-page: 2894
  year: 2008
  ident: R25-26-20140212
  publication-title: Environ Microbiol
  doi: 10.1111/j.1462-2920.2008.01706.x
– volume: 68
  start-page: 351
  year: 2009
  ident: R26-26-20140212
  publication-title: FEMS Microbiol Ecol
  doi: 10.1111/j.1574-6941.2009.00671.x
– volume: 72
  start-page: 5734
  year: 2006
  ident: R21-26-20140212
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.00556-06
– volume: 33
  start-page: 511
  year: 2005
  ident: R20-26-20140212
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gki198
– volume: 74
  start-page: 4737
  year: 2008
  ident: R31-26-20140212
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.00325-08
– volume: 105
  start-page: 16731
  year: 2008
  ident: R18-26-20140212
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0804812105
– volume: 21
  start-page: 2789
  year: 2005
  ident: R29-26-20140212
  publication-title: Bioinformatics (Oxford)
  doi: 10.1093/bioinformatics/bti394
– volume: 65
  start-page: 4799
  year: 1999
  ident: R13-26-20140212
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.65.11.4799-4807.1999
– volume: 104
  start-page: 13780
  year: 2007
  ident: R10-26-20140212
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0706625104
– volume: 71
  start-page: 1501
  year: 2005
  ident: R22-26-20140212
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.71.3.1501-1506.2005
– volume: 55
  start-page: 205
  year: 2006
  ident: R15-26-20140212
  publication-title: Gut
  doi: 10.1136/gut.2005.073817
– volume: 55
  start-page: 842
  year: 2006
  ident: R19-26-20140212
  publication-title: Gut
  doi: 10.1136/gut.2005.076604
– volume: 4
  start-page: 5
  year: 2004
  ident: R28-26-20140212
  publication-title: R News
– volume: 53
  start-page: 1
  year: 2004
  ident: R16-26-20140212
  publication-title: Gut
  doi: 10.1136/gut.53.1.1
– volume: 105
  start-page: 20858
  year: 2008
  ident: R7-26-20140212
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0808723105
– volume: 131
  start-page: 33
  year: 2007
  ident: R8-26-20140212
  publication-title: Cell
  doi: 10.1016/j.cell.2007.08.017
– volume: 134
  start-page: 577
  year: 2008
  ident: R5-26-20140212
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.11.059
– volume: 11
  start-page: 2574
  year: 2009
  ident: R30-26-20140212
  publication-title: Environ Microbiol
  doi: 10.1111/j.1462-2920.2009.01982.x
– volume: 31
  start-page: 107
  year: 1977
  ident: R9-26-20140212
  publication-title: Annu Rev Microbiol
  doi: 10.1146/annurev.mi.31.100177.000543
– volume: 127
  start-page: 412
  year: 2004
  ident: R12-26-20140212
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.04.061
– volume: 12
  start-page: 1136
  year: 2006
  ident: R32-26-20140212
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/01.mib.0000235828.09305.0c
– volume: 41
  start-page: 2915
  year: 2003
  ident: R11-26-20140212
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.41.7.2915-2923.2003
– volume: 126
  start-page: 1504
  year: 2004
  ident: R4-26-20140212
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.01.063
– volume: 72
  start-page: 263
  year: 2008
  ident: R24-26-20140212
  publication-title: J Microbiol Methods
  doi: 10.1016/j.mimet.2007.12.004
– volume: 52
  start-page: 237
  year: 2003
  ident: R17-26-20140212
  publication-title: Gut
  doi: 10.1136/gut.52.2.237
– volume: 308
  start-page: 1635
  year: 2005
  ident: R14-26-20140212
  publication-title: Science (New York)
  doi: 10.1126/science.1110591
– volume: 13
  start-page: 1403
  year: 1999
  ident: R2-26-20140212
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.1999.00630.x
– volume: 56
  start-page: 1240
  year: 2007
  ident: R33-26-20140212
  publication-title: Gut
  doi: 10.1136/gut.2006.118646
– volume: 456
  start-page: 507
  year: 2008
  ident: R6-26-20140212
  publication-title: Nature
  doi: 10.1038/nature07450
SSID ssj0020209
Score 2.45102
Snippet Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were collected from 16...
Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were...
Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Fecal samples were collected from 16...
BackgroundRecent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).MethodsFecal samples were...
Background: Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD). Methods: Fecal samples were...
Recent studies suggest that gastrointestinal (GI) microbes play a part in the pathogenesis of Crohn's disease (CD).BACKGROUNDRecent studies suggest that...
SourceID hal
proquest
pubmed
crossref
wiley
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 185
SubjectTerms 16S rRNA
Adolescent
Adult
Aged
Aged, 80 and over
Agricultural sciences
Bifidobacterium bifidum
Bioinformatics
Case-Control Studies
Crohn Disease - diagnosis
Crohn Disease - genetics
Crohn Disease - microbiology
Crohn's disease
dysbiosis
Enterococcus faecium
Escherichia coli
Eubacterium rectale
Faecalibacterium prausnitzii
Feces
Female
Gastrointestinal tract
Gastrointestinal Tract - microbiology
Gastrointestinal Tract - pathology
Genetic testing
Humans
Inflammatory bowel diseases
Intestine
Life Sciences
Male
Metagenome - genetics
microarray
Microbiota
Middle Aged
Phylogenetics
Phylogeny
Polymerase chain reaction
Primers
Probes
Prognosis
Proteobacteria
Ruminococcus
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gHgR39YXUQS9VNumm7Yn8bXsinpyYW8hbVIUtFV39fc7k2ZXF3Shh9KkbZhMJt9kJl8AjopAqTQLjC90Ufqxio2vTMv4LZNxpUwY6dxmWzyITi--7bf6bsFt4NIqRzbRGmpdF7RGfsZDgQ4PBeHO3959OjWKoqvuCI1ZmCfqMkrpSvo_DlfQpHigh0Mh_iwdMQsF0dlzrk8jxApiYj6afaJsyImdbr8A5yR-tRNQexmWHHJkF01Xr8CMqVZh4d7FxtegSykbL-Rr42zEEC0zlCBaNjRm-AajLZWUFmQZVFldsquP-qk6HjAXomGvzw0n01CtQ69983jV8d1BCX6B7p3w4zxMuEKkEwVFkaCTEOWpQs_IGFHqDOWC4xqhlUrTMuGcG8RYhBR0EpsW16XgGzBX1ZXZAsYRsaGzjbBEibggOjItRJkSyXymMqM9OBmJSxaORZwOs3iRDf9xJFGy0krWg8Nx1beGOuPPSijzcTmRXXcu7iQ9C0KLX-Ov0IM97JJpH9kddZZ0Q3AgfxTGg4NxMQ4eioioytSfA2ntUSJQdzxg_9RJ8RcEm_Azm40ejBuCUqR9yikKxSrG_y2U3ctre7M9vak7sNgsWtO1C3PDj0-zh6hnmO9b1f4Gawj6qQ
  priority: 102
  providerName: ProQuest
Title Highlighting new phylogenetic specificities of Crohn's disease microbiota
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fibd.21436
https://www.ncbi.nlm.nih.gov/pubmed/20722058
https://www.proquest.com/docview/3169785250
https://www.proquest.com/docview/1017976119
https://www.proquest.com/docview/821481900
https://hal.science/hal-01000994
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD7qijTxMi6DEegqgyaxl7S5Oo54WseqDrEKVZvUByTLSRy1oktRLzzw6znHuUARRQgpD1F8iePjY38n5_gzwFnqKCViR9s8S3M7UIG2lQ61HerYV0q7XpaYaIsxH90FH6bhtAXv6r0wJT9E88ONNMPM16TgKln3f5KGzpOs5-FqT3TbFKtFgGjSUEehTW_CO9C6Ifd-LGpWIcfrNyV31qKDGUVC7uxy-wVs7mJXs_gMH8HnutllzMmX3naT9NLvvzE6_ud3PYajCpSyi3IUPYGWLp7C4U3ldj-Ga4oGWZAZjwsdQyDOUDj4dpwnsQSj3ZoUcWTIWdkyZ5er5ax4u2aV94fdz0u6p416BnfDq9vLkV2dwWCnaDlyO0jcyFcIojwnTSO0P7xEKDS6tOZ5FsehwCkDUZsSIo9839cI3wiEZFGgQz_Luf8c2sWy0C-AoYwctOMR8SgepMR0lnGeC-Kvj1WsMwvOa2nItCIop3MyFrKkVvYkdo00XWPBmybr15KV44-ZUKRNOvFojy4-SnrmuAYaB99cC05R4n-rpFOPBVlp91r6LkfjmxzCFrxuklEvydmiCr3crqWZ6iLuurEFbE8ega8gRIbVnJTDrGkI9iJtgRbYKWaw7G-hvB68Nzcv_z3rK3hY_hunqwPtzWqrTxFcbZIuHETTqAsPBlfjT5Ou0akfgkoc9g
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61Wwm4oPIOtGAQCC6hSZw4zgGhPrVLtyuEWqk314kdtVJJSndL1T_V38iM84CVaG-Vcohix7HG4_E3mfFngPdFoLXMAusLU5R-rGPra5tYP7EZ19qGkcldtsVEDA_ib4fJ4QJcd3thKK2ys4nOUJu6oH_kazwU6PBQEO7r2S-fTo2i6Gp3hEajFrv26hJdtumX0RaO74co2tne3xz67akCfoG-kPDjPEy5RlgQBUWRIqKOcqnRjbBWlCbLEomTAHGIlrJMOecWAQktqyaNbcJNKTi2uwhLMUdXZgBLG9uT7z96Fy9okkrQp6Kkgkx2XEZBtHaSm88RohMxtwIuHlP-5dzeun8g7jxidkvezjI8bLEqW2-U6xEs2Oox3Ntro_FPYERJIqfk3eP6xxCfMxwztKVoPvENRps4KRHJcbayumSb5_Vx9XHK2qAQ-3nSsEDN9FM4uBMhPoNBVVf2BTCOGBHdewRCWsQFEaAZIUpJtPaZzqzx4FMnLlW0vOV0fMapahiXI4WSVU6yHrzrq541ZB3_rYQy78uJXnu4Plb0LAgdYo5_hx6s4pDc1shKN1iqnfRT9VdFPXjbF-N0pRiMrmx9MVXOAqYiDDMP2A11JH6CgBo287zRg74jKEXaGS1RKE4xbu6hGm1suZuXt3f1Ddwf7u-N1Xg02X0FD5pf5nStwGB2fmFXEXPN8tetojM4uuu59Qc0ETW9
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlVAvhdKWhkfrokrtJUsSJ44jTsB2tQsUVVWROFSynNgRCMgidpdDf31nnEfZqlRVpRyi-BHHnrG_yYw_A7wvAq1lFlhfmKL0Yx1bX9vE-onNuNY2jEzuoi1OxfAsPjpPzhdgr90LU_NDdD_cSDPcfE0KfmvK3V-koZe56UW42otFeBKLQJJI97923FFo1Lv4DjRvyL-fyZZWKIh2u6Jzi9HiBYVCzm1ze4A258GrW30GK_C9bXcddHLVm03zXvHjN0rH__ywVXjWoFK2X4vRc1iw1Rosf2787i9gROEg12TH40rHEIkzHB18O06UWILRdk0KOXLsrGxcssO78UX1YcIa9w-7uaz5nqb6JZwNPn07HPrNIQx-gaaj8OM8TLlGFBUFRZGiARLlUqPVZa0oTZYlEucMhG1ayjLlnFvEb4RCTBrbhJtS8FewVI0r-xoYRzSIhjxCHi3igqjOjBClJAL7TGfWePCxHQ1VNAzldFDGtaq5lSOFXaNc13iw02W9rWk5_pgJh7RLJyLt4f6JomdB6LBxfB96sI0j_rdKtlpZUI16TxQPBVrf5BH24F2XjIpJ3hZd2fFsotxcl4owzDxgj-SR-AqCZFjNei1mXUOwF2kPtMROccLyeAvV6KDvbjb-PetbWP7SH6iT0enxJjyt_5PTtQVL07uZ3UagNc3fOIX6CUIRHUg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Highlighting+New+Phylogenetic+Specificities+of+Crohn%27s+Disease+Microbiota&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Mondot%2C+Stanislas&rft.au=Kang%2C+S.+S.&rft.au=Furet%2C+J-Pierre+J.-P.&rft.au=de+Carcer%2C+D.+Aguirre+D.+A.&rft.date=2011&rft.pub=Lippincott%2C+Williams+%26+Wilkins&rft.issn=1078-0998&rft.eissn=1536-4844&rft.volume=17&rft.issue=1&rft.spage=185&rft.epage=192&rft_id=info:doi/10.1002%2Fibd.21436&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_01000994v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon